Studies remote video-observed inhaler therapy in children with asthma
Compares remote video-observed inhaler care with usual clinic care in children with asthma.
Plain-language title generated from the registry record
Registry title: Cohort Multiple Randomized Controlled Trial in Pediatric Asthma
Key facts
- Where
- Enschede, NetherlandsSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers with asthma who are patients at the children's department of Medisch Spectrum Twente. It builds a cohort to test eHealth interventions.
- Age
- 4 to 18 years
- Sex
- All sexes can join.
- Disease stage
- Asthma diagnosed by a pediatrician following the GINA 2022 guidelines. This needs typical symptoms plus a lung test (spirometry) showing variable airflow limitation.
- Biomarker or test result
- Spirometry result showing variable airflow limitation, by at least one of these: reduced FEV1/FVC (Z-score ≤ -1.64), FEV1 increase >12% after a bronchodilator, FEV1 decrease ≥ 13% in an exercise challenge test, or FEV1 variation >12% pred between tests on different dates.
Main reasons for not taking part
- The child or parent(s) do not speak enough Dutch to understand and answer questions
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 4 and 18 years old?
Source: NCT06278662, who can take part
Where in Netherlands
- Medisch Spectrum TwenteEnschede, NetherlandsContact: Job van der Palen, Full professorTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Mattienne van der Kamp
- Trial code
- NCT06278662
- Record updated
- 26 November 2024
- Original description
The overarching goal of this study is to optimize pediatric asthma care and to continuously evaluate variations/innovations of the care (including transformation to remote eHealth care).Read full original descriptionShow less
Cohort Multiple Randomized Controlled Trial in Pediatric Asthma: Infrastructure to Assess the Long- and Short-term Effects of (eHealth) Interventions.
The overarching goal of this study is to optimize pediatric asthma care and to continuously evaluate variations/innovations of the care (including transformation to remote eHealth care).
Primary Objectives within cmRCT cohort:
* Provide a framework for multiple randomized (eHealth) interventions for asthmatic children * Generate short- and long-term data on Quality of life (QoL), asthma outcomes (asthma control, lung function), quality of care, self-management capacity, healthcare use, and therapy compliance in a representative secondary care pediatric asthma cohort.
Secondary Objectives within cmRCT cohort:
* Evaluate current pediatric asthma care at the Pediatric department of Medisch Spectrum Twente, in order to explore possible improvements for the pediatric asthma care. * Compare the short and long-term asthma outcomes between the eHealth care path and the outpatient care path. * Compose patient risk profiles that include both personal, clinical and exposome markers and clinical asthma endpoints (for example clinical admission/exacerbations).
Inclusion: Is 4 to 18 years old; Is patient at the children's department at Medisch Spectrum Twente at moment of inclusion; Is diagnosed with asthma by a pediatrician following the Global Initiative for Asthma(GINA) guidelines 2022 [8]:; *Medical history fitting asthma diagnosis:; Based on (typical) symptoms: (nighttime) wheezing, dyspnea, coughing (triggered by either viral infections, exercise, allergens or weather changes); (Possibly) supplemented with a family history/atopy; AND; *Spirometry variable expiratory airflow limitation by at least one of these criteria:; FEV1/FVC reduced compared to lower limit of normal(Z-score ≤ -1.64); Positive bronchodilator responsiveness(increase FEV1>12%); Positive Exercise Challenge Test (ECT)(decrease FEV1≥ 13%); Excessive variation in lung function (LF) between tests from different dates (variation FEV1>12% pred).
Exclusion: The child and/or parent(s) has/have insufficient command of the Dutch language resulting in the insufficient ability to understand and/or answer questions.